Home > Income Statement > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Consolidated Net Profit

    Back to Income Statement
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Consolidated Net Profit ₹25 Cr₹20 Cr₹20 Cr₹1,053,410 Cr₹10 Cr

What is the latest Consolidated Net Profit of SYNCOM FORMULATIONS (INDIA) ?

The latest Consolidated Net Profit ratio of SYNCOM FORMULATIONS (INDIA) is ₹25 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹25 Cr
Mar2024₹20 Cr
Mar2023₹20 Cr
Mar2022₹1,053,410 Cr
Mar2017₹10 Cr

How is Consolidated Net Profit of SYNCOM FORMULATIONS (INDIA) Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹25 Cr
26.12
Mar2024 ₹20 Cr
1.42
Mar2023 ₹20 Cr
-100.00
Mar2022 ₹1,053,410 Cr
10,171,878.56
Mar2017 ₹10 Cr -

Compare Consolidated Net Profit of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,377.1 Cr -1% -10.6% -31% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,705.0 Cr -0.2% 1.1% -0.4% Stock Analytics
DIVIS LABORATORIES ₹167,091.0 Cr 0.7% -2.9% 6.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹127,555.0 Cr -0.9% -1.6% 13.6% Stock Analytics
CIPLA ₹120,919.0 Cr 0.7% -2.4% 4.2% Stock Analytics
DR REDDYS LABORATORIES ₹106,165.0 Cr 2.2% 2.8% 2.8% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-1%

-10.6%

-31%

SENSEX

0.2%

-0.5%

4%


You may also like the below Video Courses